StockNews.com Initiates Coverage on T2 Biosystems (NASDAQ:TTOO)

StockNews.com started coverage on shares of T2 Biosystems (NASDAQ:TTOO) in a research note published on Saturday. The brokerage issued a sell rating on the medical equipment provider’s stock.

T2 Biosystems Stock Up 10.8 %

Shares of NASDAQ TTOO opened at $0.12 on Friday. The firm’s 50-day moving average is $0.12 and its two-hundred day moving average is $0.43. T2 Biosystems has a 12-month low of $0.06 and a 12-month high of $6.80.

About T2 Biosystems

T2 Biosystems, Inc, an in vitro diagnostics company, develops and sells diagnostic products and product candidates in the United States and internationally. Its technology enables detection of pathogens, biomarkers, and other abnormalities in various unpurified patient sample types, including whole blood, plasma, serum, saliva, sputum, cerebral spinal fluid, and urine.